Related Experiment Videos

Pharmacokinetics of digoxin in low-birth-weight infants

Developmental Pharmacology and Therapeutics
|January 1, 1982
PubMed

Insights

Digoxin pharmacokinetics in low-birth-weight infants show that half-life is inversely related to gestational age and weight. Total body clearance is highly dependent on these factors, informing digoxin dosage recommendations.

Area of Science:

  • Neonatal Pharmacology
  • Pediatric Pharmacokinetics

Background:

  • Digoxin is frequently prescribed for low-birth-weight infants.
  • Understanding digoxin's behavior in this population is crucial for safe and effective therapy.

Purpose of the Study:

  • To investigate the pharmacokinetics of digoxin in low-birth-weight infants.
  • To establish relationships between pharmacokinetic parameters and infant characteristics.

Main Methods:

  • Studied 13 low-birth-weight infants (820–2,710 g, 26–38 weeks gestational age).
  • Utilized an open two-compartment model to describe digoxin distribution and elimination.
  • Analyzed correlations between pharmacokinetic parameters (Vd, half-life, clearance) and gestational age/weight.

Main Results:

  • Volume of distribution showed poor correlation with gestational age and weight.
  • Digoxin half-life was inversely related to gestational age and weight (r=0.69 and 0.66).
  • Total body digoxin clearance was highly dependent on gestational age and weight (r=0.87 and 0.88).

Conclusions:

  • Digoxin's elimination and half-life in low-birth-weight infants are significantly influenced by gestational age and weight.
  • Recommended digitalizing and maintenance digoxin dosages based on these findings.

Related Concept Videos